Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

50-nm nanoparticles are better at penetrating skin and targeting hair follicles for drug delivery than 100-nm ones.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Hinokiflavone may help treat cancers and other health issues.

A specific gene mutation causes vitamin D resistance, but certain vitamin D analogs might help.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

Pexidartinib often causes liver issues and fatigue, especially in women.

India is ideal for dermatology trials due to diverse patients and cost-effectiveness.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Pandan Wangi leaves and Noni fruit extracts can help fight dandruff-causing fungi.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

Diphencyprone can cause unexpected and possibly permanent vitiligo.

Acyclovir can prevent rejection of skin grafts in herpes-related lip leucoderma.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Improved finasteride formula allows slow, sustained release and better absorption for patients.

New method accurately measures finasteride in tablets.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

4-octyl itaconate may prevent hearing loss caused by the drug cisplatin by activating certain cell protection pathways.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Mutations in the spike protein affect drug binding and effectiveness.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.